iTRAQ-Based Proteomic Analysis of Ginsenoside F2 on Human Gastric Carcinoma Cells SGC7901
Ginsenoside F2 (F2), a protopanaxdiol type of saponin, was reported to inhibit human gastric cancer cells SGC7901. To better understand the molecular mechanisms of F2, an iTRAQ-based proteomics approach was applied to define protein expression profiles in SGC7901 cells in response to lower dose (20 ...
Main Authors: | Qian Mao, Pin-Hu Zhang, Jie Yang, Jin-Di Xu, Ming Kong, Hong Shen, He Zhu, Min Bai, Li Zhou, Guang-Fu Li, Qiang Wang, Song-Lin Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2016/2635483 |
Similar Items
-
Ginsenoside Rg3 inhibits the biological activity of SGC‐7901
by: Qing Yang, et al.
Published: (2020-08-01) -
Andrographolide Inhibits Proliferation and Metastasis of SGC7901 Gastric Cancer Cells
by: Lei Dai, et al.
Published: (2017-01-01) -
Effect of Evodiamine on Inducing Apoptosis of Human Gastric Cancer Cell Line SGC-7901 in Vitro
by: LIU Shao-ping, et al.
Published: (2014-09-01) -
Autophagy Protects from Raddeanin A-Induced Apoptosis in SGC-7901 Human Gastric Cancer Cells
by: Yu-hao Teng, et al.
Published: (2016-01-01) -
Rhein induces apoptosis of human gastric cancer SGC-7901 cells via an intrinsic mitochondrial pathway
by: Yiwen Li, et al.
Published: (2012-11-01)